In Latin America and the Caribbean, 33,000 women die of cervical cancer each year. What is blocking universal access to testing and treatment?
Only two steps remain in Iowa’s legislative quest to require insurance companies to provide coverage of vaccinations for the human papillomavirus, the major cause of cervical cancer.
Women’s access to unbiased, medically-sound reproductive health care in Canada is being compromised by doctors hiding behind conscience clauses to refuse services and referrals.
Both male circumcision and the new HPV vaccine have been called “no-brainers” in the fight to reduce HIV and HPV infection rates. But are they really the magic bullet solutions that they seem to be?
A new study has found that administering the HPV vaccine based on a woman’s risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.
Despite the recognized benefits of universal programs aimed at young girls there is still a need to raise concerns about vulnerable and disadvantaged groups of women who are simply falling through the cracks.